Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Edgewise Therapeutics Inc (NQ: EWTX ) 18.73 -2.45 (-11.57%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,129,565 Open 21.29 Bid (Size) 18.70 (3) Ask (Size) 19.94 (1) Prev. Close 21.18 Today's Range 18.41 - 21.52 52wk Range 5.120 - 23.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Stock Market News For July 23: Quick Takes On GE Aerospace, Boeing, Biotechs July 23, 2024 What sectors outperformed after Trump won the 2016 election, and which outperformed during his term? Via Investor's Business Daily Topics Government Exposures Political Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense July 16, 2024 Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine. Via Investor's Business Daily Performance YTD +70.27% +70.27% 1 Month +12.09% +12.09% 3 Month +16.26% +16.26% 6 Month +22.26% +22.26% 1 Year +167.95% +167.95% More News Read More Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day May 13, 2024 Via Investor's Business Daily Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024 May 10, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics: Q4 Earnings Insights February 22, 2024 Via Benzinga How Is The Market Feeling About Edgewise Therapeutics? January 31, 2024 Via Benzinga EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 May 09, 2024 Via Benzinga Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors May 07, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM) May 06, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophies April 23, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker) April 15, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session March 28, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024 March 27, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024 March 05, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference February 28, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights February 22, 2024 From Edgewise Therapeutics Via Business Wire Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne) February 13, 2024 From Edgewise Therapeutics Via Business Wire Insider Favorites: 7 Stocks with Bullish Buying Signals February 11, 2024 Via InvestorPlace Insiders Buying Edgewise Therapeutics And 2 Other Stocks January 26, 2024 Via Benzinga Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 19, 2024 Via Benzinga What's Going On With Edgewise Therapeutics Stock? January 19, 2024 Via Benzinga World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday January 19, 2024 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
